Sessioni Comunicazioni Orali


Pharmacology of antineoplastic drugs - Session II

Venerdì 30 Ottobre 2015 / 11.00-13.00
19Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction
Tognolini M., Giorgio C., Incerti M., Castelli R., Festuccia C., Rusnati M., Vacondio F., Russo S., Pala D., Callegari D., Mor M., Bertoni S., Ballabeni V., Lodola A., Barocelli E.
159RNA-Seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A
Bergamo A., Gerdol M., Lucafò M., Pelillo C., Battaglia M., Pallavicini A., Sava G.
179Carbonic anhydrase IX: target enzyme for diagnosis and therapy of renal cell carcinoma
Lucarini L ., Durante M., Lanzi C., Formicola G., Supuran C., Crisci A., Masini E.
264Role of microRNAs in the activity of new therapeutic inhibitors of Src kinases in CD133+ colorectal cancer cells
Muscari I., Adorisio S., Rossetto A., Botta M., Falco G., Riccardi C., Liberati AM., Delfino DV.
380Targeted gold nanoparticles as nanosonosensitizers in ultrasound based cancer treatment
Serpe L., Canaparo R., Fantozzi R., Barazzale C., Racca L., Foglietta F., Durando G., Caliceti P., Salmaso S.
406Preclinical safety assessment of cytotoxic and biotechnology anticancer drugs complying with the regulatory, scientific and ethical aspects… what a challenge!
Andreini I., Oberto G.
440Resveratrol exerts anti-proliferative and pro-apoptotic effects through transcription factor REST in human medulloblastoma cells
Baiula M., Spampinato S.
484Monoacylglycerol lipase is crucially involved in experimental colon carcinogenesis
Romano B., Orlando P., Di Marzo V., Morbidelli L., Borrelli F., Izzo AA., Pagano E.